Summer Sale

50% off Premium Yearly

00days
00hrs
00mins
00secs

NYSEARCA:IHI

ISHARES DOW JONES US MEDICAL DEV.(ETF) (IHI)

49.28
+0.21 (0.43%)
as of Jun 18, 2026, 8:54:17 pm Market Open.
53 watching
0
BUY
He likes this. Medical devices play to an aging demographic. The risk is political intereference with governments issuing new laws that interfere with this sector.
PAST TOP PICK
(A Top Pick May 09/18, Up 16%) He sees this continuing to be a good performer. It will follow the market up and down, but will do a little better in the long run. The ETF helps reduce the risk of picking a single company. He has backed away from healthcare, but still still holds this.
PAST TOP PICK
(A Top Pick Apr 11/18, Up 25%) It is high quality with a 1.0 beta. He would stick with it as the fundamental still hold true -- aging population, diabetes, etc. There are 29 million US adults with Type 2 diabetes and another 84 million are pre-diabetic -- almost 1 in 3 adults.
BUY
He likes because it gives diversification away from the big pharma. Nothing wrong with this one.
BUY
IXJ vs. IHI IXJ is well-diversified and global and prefers this to IHI. It has an overlay of healthcare technology, which is exciting particularly technology. IHI is fine, too. Buy one-third IXJ and one-third IHI.
BUY
IXJ vs. IHI IXJ is well-diversified and global and prefers this to IHI. It has an overlay of healthcare technology, which is exciting particularly technology. IHI is fine, too. Buy one-third IXJ and one-third IHI.
PAST TOP PICK
(A Top Pick Nov 23/18, Up 6%) Nov.25-Feb.14 is seasonality which coincides with several healthcare conferences. These medical stocks are still outperforming the market. He took profits.
COMMENT
What comes screaming back is the previous leaders. There is persistence. Internet retail is the first one to break down and the first one to reverse. Basic materials are the area starting to make a turn. It would be complimentary to add some Canada.
TOP PICK
He likes the end-market growth story -- knees, hips, joints, etc. High-quality with a high market beta -- this is not a defensive ETF. A broad basket with a diversified portfolio. Yield 0.36%
PAST TOP PICK
(A Top Pick Jan 11/18, Up 8%) Likes it. There are really two robust parts of the healtcare sector, one is this one, medical devices and equipment, and the other is managed care. You are buying market beta here; if the market goes down, IHI is going down. They might be high quality and good cash flow, but don't think of this as safety. Loves it and would stick with it.
TOP PICK
Healthcare has performed phenomally this year, avoiding cyclical breakdowns found in other sectors. Seasonally, it's Nov.24-Feb.14. Aging demographics help, but really pushes this are all the healthcare conferences at the start of the year. These stocks run up till then.
TOP PICK
He likes medical devices – worldwide hospital spending, changing demographics. It has great tailwinds. They are less politically charged than drug prices.
TOP PICK

He likes the healthcare space. This is a high-quality beta play in the space. Don’t expect it to be super defensive, but thinks global hospital spending will continue to rise.

TOP PICK

It's feeding into the demographic of aging baby boomers. This includes medical devices like Abbott Labs. Also likes it because it's U.S. and diversifies from big pharma.

DON'T BUY

Medical devices have been fantastic the last 5 years. Like tech, we’re there already. PE is 40x, so a lot of the growth has already happened. It’s just too late.

Showing 16 to 30 of 44 entries